[Interleukin-1, inflammasome and autoinflammatory diseases].

Area of Science:

• Immunology
• Molecular Biology
• Pathophysiology

Background:

• Interleukin-1 (IL-1) is a central cytokine in innate immunity and inflammation.
• IL-1 mediates systemic effects including fever, thrombopoiesis, granulopoiesis, and leukocyte recruitment.
• IL-1 is implicated in inflammatory diseases like diabetes and gout, and autoinflammatory conditions such as cryopyrinopathies and familial Mediterranean fever.

Purpose of the Study:

• To provide a comprehensive review of Interleukin-1 (IL-1).
• To detail the synthesis, activation, signaling, and regulation of IL-1.
• To describe the role of IL-1 in autoinflammatory and related diseases.

Main Methods:

• Literature review of scientific articles on Interleukin-1.
• Analysis of the molecular mechanisms of IL-1 synthesis and activation.
• Description of IL-1 signaling pathways and regulatory processes.
• Examination of the pathological involvement of IL-1 in various diseases.

Main Results:

• IL-1 synthesis and activation are tightly regulated processes.
• Constitutional inflammasome defects lead to IL-1 hypersecretion in certain autoinflammatory diseases.
• Complex pathophysiologies involving IL-1 pathway deregulation are observed in other autoinflammatory conditions.
• IL-1 plays a critical role in the pathogenesis of numerous inflammatory and autoinflammatory diseases.

Conclusions:

• Interleukin-1 is a crucial mediator in immunity and inflammation.
• Dysregulation of the IL-1 pathway is central to the pathophysiology of many autoinflammatory diseases.
• Understanding IL-1 biology is essential for developing targeted therapies for inflammatory conditions.